Leads To Development (L2D) is a privately owned organisation that was formed in 2009 as a high value service company that provides support to clients developing innovative therapies. Based in Paris, France, L2D’s international team provides hands-on scientific, regulatory and project management expertise across all stages of drug development.
Historically, L2D’s core expertise centred on CMC and non-clinical aspects of drug development, primarily focused on the earlier stages, from discovery to the first tests in humans. Today, we support our clients throughout their entire development programmes, up to licensure application, and offer a widened range of services, including clinical trial oversight. Our know-how spans multiple indications and therapeutic product classes, from new chemical entities (small molecules), to peptides, biologics and implantable medical devices.
The expertise we have built allows our clients to increase the chances of successfully developing their promising new drugs, whilst reducing the time taken to reach their development milestones.
